Eli Lilly and Company
Price
OptionsOpen the Sheet →FilingsNewest: 10-Q, Quarterly reportAug 5 →InsidersNo open-market buys. 3 insiders sold $2.83B, 2 of 272 sales on a 10b5-1 plan. 2 trades with a filed price far from the stock's price are left out of the dollars.→HoldersLilly Endowment 9.6%BlackRock 7.1%Vanguard 5.7%→PeersClosest companies: AMGN, PFE, REGN→
From the filings
Figures
- Revenue
- $79.67Blast 12 months
- Net income
- $26.71Blast 12 months
- Operating cash flow
- $20.48Blast 12 months
- Cash and equivalents
- $8.95Bat the last balance sheet
- Total debt
- $54.91Bat the last balance sheet
- Shares outstanding
- 944.8M shareson issue